OBJECTIVES
  • Describe the pathophysiology and clinical manifestations of sickle cell anemia 
  • Review the pharmacology of agents used for prevention and treatment of vaso-occlusive crisis 
  • Evaluate primary literature regarding the approval of Voxelotor in the management of sickle cell anemia
Add to calendar: 
Session date: 
01/20/2021 - 2:00pm to 2:30pm EST

Please login or register to take this course.